Simultaneous inhibition of CXCR1/2, TGF-β, and PD-L1 remodels the tumor and its microenvironment to drive antitumor immunityLucas A. Horn, Claudia Palena|Journal for ImmunoTherapy of Cancer|2020Cited by 96
570 Blockade of the inhibitory collagen receptor LAIR-1, PD-L1, and TGF-β promotes anti-tumor activity through T cell activation and myeloid cell polarizationLucas A. Horn, Claudia Palena, Kristen Fousek et al.|Regular and Young Investigator Award Abstracts|2021Cited by 0